Editorial Comment to Effect of improved systemic therapy on patient survival in metastatic non‐clear‐cell renal cell carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Urology"
DOI: 10.1111/iju.14536
Abstract: A greater understanding of molecular biology has led to major breakthroughs in medical treatment for patients with metastatic renal cell cancer (mRCC). Various agents, including inhibitors of vascular endothelial growth factor and mammalian target of… read more here.
Keywords: ccrcc; non ccrcc; urology; therapy ... See more keywords
Molecular Characterization of m6A Modifications in Non-Clear Cell Renal Cell Carcinoma and Potential Relationship with Pathological Types
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of General Medicine"
DOI: 10.2147/ijgm.s348343
Abstract: Background N6-Methyladenosine (m6A) modification is a eukaryotic mRNA modification that modulates the fate of modified RNA and, therefore, the expression of proteins. m6A modifications are associated with important roles in several cancers. Most studies related… read more here.
Keywords: cell carcinoma; cell; non ccrcc; m6a modifications ... See more keywords